Table 1.
Demographics
| n (%) or mean±SD | |
| n | 430 |
| Male | 318 (74) |
| Age (years) | 67±10 |
| BMI, kg/m2 | 26.8±4.1 |
| Smoking status | |
| Never | 189 |
| Quit | 146 |
| Active | 95 |
| Hypertension | 292 (68) |
| Diabetes | 116 (27) |
| Dyslipidaemia | 378 (88) |
| Prior PCI of target vessel | 60 (14) |
| History of MI | 116 (27) |
| Total cholesterol, mg/dL | 188.9±44.4 |
| LDL, mg/dL | 108±36.7 |
| HDL, mg/dL | 49.0±15.3 |
| TG, mg/dL | 128±92.3 |
| HbA1c, % | 6.1±1.4 |
| Creatinine, mg/dL | 0.9±0.20 |
| BNP, ng/L | 70.9±89.3 |
| LVEF % | 60±9.0 |
| Medications | |
| Aspirin | 383 (89) |
| Second antiplatelet | 297 (69) |
| Beta-blocker | 262 (61) |
| Calcium antagonist | 151 (35) |
| Nitrates | 198 (46) |
| Statin | 344 (80) |
| RAAS antagonist | 69 (16) |
| Diuretic | 77 (18) |
| Anti-diabetes | 60 (14) |
BMI, body mass index; BNP, brain-natriuretic peptide; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention; RAAS, renin aldosterone angiotensin system; TG, triglyceride.